Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-20-000002

SVP, Chief Legal Officer gave up 8,188 shares (to pay taxes)

  • SVP, Chief Legal Officer acquired 27,614 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BUCHEN DAVID A SVP, Chief Legal Officer 2020-01-03 Option exercise +27,614 28,614 D
BUCHEN DAVID A SVP, Chief Legal Officer 2020-01-03 Shares withheld for taxes −8,188 $4.72 $38,647 20,426 D
Derivatives
BUCHEN DAVID A SVP, Chief Legal Officer 2020-01-03 Option exercise · Restricted Stock Units −27,614 82,843 D
Loading xslF345X03/wf-form4_157834922391058.xml…